Bioleap

Curated by Signal

Drug design company developing complex biologics

Overview

Drug design company developing complex biologics. The company uses proprietary in-silico R&D platform, leveraging physics biophysical models and AI to develop biologics, particularly immuno-oncology therapies.

Key facts

Founded: 2022
Headquarters: Cambridge, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Odhealth
Provider of an online teleconsultation platform with nutritionists
Health TechnologyLondon, United Kingdom
I Navigator
Provider of community referral case management platform for healthcare
Health TechnologyCaerphilly, United Kingdom
Bubbzy
Platform offering parenting tool designed to assist parents
Health TechnologyLondon, United Kingdom

About Bioleap

What does Bioleap do?

Drug design company developing complex biologics.

Where is Bioleap headquartered?

Bioleap is headquartered in Cambridge, United Kingdom.

When was Bioleap founded?

Bioleap was founded in 2022.

Which sector is Bioleap in?

Bioleap operates in Health Technology.

Who are Bioleap's competitors?

Companies similar to Bioleap include Odhealth, I Navigator, and Bubbzy.